| Literature DB >> 23727191 |
Jorge Alonso-Gutierrez1, Rossana Chan, Tanveer S Batth, Paul D Adams, Jay D Keasling, Christopher J Petzold, Taek Soon Lee.
Abstract
Limonene is a valuable monoterpene used in the production of several commodity chemicals and medicinal compounds. Among them, perillyl alcohol (POH) is a promising anti-cancer agent that can be produced by hydroxylation of limonene. We engineered E. coli with a heterologous mevalonate pathway and limonene synthase for production of limonene followed by coupling with a cytochrome P450, which specifically hydroxylates limonene to produce POH. A strain containing all mevalonate pathway genes in a single plasmid produced limonene at titers over 400mg/L from glucose, substantially higher than has been achieved in the past. Incorporation of a cytochrome P450 to hydroxylate limonene yielded approximately 100mg/L of POH. Further metabolic engineering of the pathway and in situ product recovery using anion exchange resins would make this engineered E. coli a potential production platform for any valuable limonene derivative.Entities:
Keywords: Escherichia coli; Limonene; Metabolic engineering; Mevalonate pathway; Microbial production; Perillyl alcohol
Mesh:
Substances:
Year: 2013 PMID: 23727191 DOI: 10.1016/j.ymben.2013.05.004
Source DB: PubMed Journal: Metab Eng ISSN: 1096-7176 Impact factor: 9.783